Memantine in the prevention or alleviation of electroconvulsive therapy induces cognitive disorders: A placebo controlled trial

被引:14
作者
Abbasinazari, Mohammad [1 ]
Adib-Eshgh, Ladan [1 ]
Rostami, Azin [1 ]
Beyraghi, Narges [2 ]
Dabir, Shideh [3 ]
Jafari, Reyhaneh [4 ]
机构
[1] Shahid Beheshti Univ Med Sci, Dept Clin Pharm, Tehran, Iran
[2] Shahid Beheshti Univ Med Sci, Taleghani Hosp, Dept Psychiat, Tehran, Iran
[3] Shahid Beheshti Univ Med Sci, Akhtar Hosp, Dept Anesthesiol, Tehran, Iran
[4] Univ Tehran Med Sci, Student Sci Res Ctr, Tehran, Iran
关键词
Memantine; Electroconvulsive therapy; Cognition; Modified Mental State Examination;
D O I
10.1016/j.ajp.2015.04.002
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
The purpose of this study was to evaluate the effect of memantine administration on the adverse cognitive effects of electroconvulsive therapy (ECT). Forty patients diagnosed with a major depressive disorder for which ECT was indicated as a treatment for their current episode were randomly allocated to either the memantine (5 mg/day) group or the placebo group. All patients underwent the same protocol for anaesthesia and ECT procedures. The patients received memantine or the placebo for the whole period of ECT treatment, starting the day before ECT and continuing until the fourth session of ECT. The Modified Mental State Examination (MMSE) was used for the assessment of cognition before and after the trial. Regarding MMSE and item 3 MMSE (related to recent memory), the memantine group scored significantly higher at the end of ECT sessions than the control group (P = 0.02, P < 0.001, respectively). Our data support the hypothesis that memantine may reduce cognitive impairment following ECT. Memantine could be both a safe and well- tolerated treatment for use with ECT. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:5 / 9
页数:5
相关论文
共 21 条
[1]   Possible glutamatergic and lipid signalling mechanisms in ECT-induced retrograde amnesia: Experimental evidence for involvement of COX-2, and review of literature [J].
Andrade, Chittaranjan ;
Singh, Nagendra M. ;
Thyagarajan, S. ;
Nagaraja, Nandakumar ;
Rao, N. Sanjay Kumar ;
Chandra, J. Suresh .
JOURNAL OF PSYCHIATRIC RESEARCH, 2008, 42 (10) :837-850
[2]  
[Anonymous], GERMAN J PSYCHIAT
[3]   Memantine in patients with Alzheimer's disease receiving donepezil: new analyses of efficacy and safety for combination therapy [J].
Atri, Alireza ;
Molinuevo, Jose L. ;
Lemming, Ole ;
Wirth, Yvonne ;
Pulte, Irena ;
Wilkinson, David .
ALZHEIMERS RESEARCH & THERAPY, 2013, 5 (01)
[4]   A glutamatergic model of ECT-induced memory dysfunction [J].
Chamberlin, E ;
Tsai, GE .
HARVARD REVIEW OF PSYCHIATRY, 1998, 5 (06) :307-317
[5]  
Corbett A, 2012, EXPERT REV NEUROTHER, V12, P535, DOI [10.1586/ern.12.43, 10.1586/ERN.12.43]
[6]   MINI-MENTAL STATE - PRACTICAL METHOD FOR GRADING COGNITIVE STATE OF PATIENTS FOR CLINICIAN [J].
FOLSTEIN, MF ;
FOLSTEIN, SE ;
MCHUGH, PR .
JOURNAL OF PSYCHIATRIC RESEARCH, 1975, 12 (03) :189-198
[7]   EFFECTS OF ECT AND DEPRESSION ON VARIOUS ASPECTS OF MEMORY [J].
FRITH, CD ;
STEVENS, M ;
JOHNSTONE, EC ;
DEAKIN, JFW ;
LAWLER, P ;
CROW, TJ .
BRITISH JOURNAL OF PSYCHIATRY, 1983, 142 (JUN) :610-617
[8]   A RATING SCALE FOR DEPRESSION [J].
HAMILTON, M .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1960, 23 (01) :56-62
[9]   Memantine in dementia: a review of the current evidence [J].
Herrmann, Nathan ;
Li, Abby ;
Lanctot, Krista .
EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (05) :787-800
[10]  
John D.M., 2008, J PSYCHIATR RES, V42, P526